15-min delayed · Jul 27, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 6 firms covering Pulmonx Corp, 4 rate it Buy or better, 2 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. The target range is very wide, $2.50 to $14.00 (about 5.6x), which points to deep disagreement over how to value the company rather than near-term timing. The average target of $5.58 sits 356% above the current $1.23. The rating mix has stayed broadly stable, with Buy-side ratings easing from 4 to 3 over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.29 next quarter toward $-1.04 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS6 ratings
Moderate Buy
Strong Buy00%
Buy467%
Hold233%
Sell00%
Strong Sell00%
Based on 6 analysts giving stock ratings to Pulmonx Corp.
As of Jul, 3 of 4 firms rate LUNG a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
LUNG EPS & revenue forecast
EPS · NEXT QUARTER
$-0.29
Range $-0.30 – $-0.27 · 5 analysts · -16% YoY
Next period, 5 analysts expect Pulmonx Corp to earn $-0.29 a share (range $-0.30 – $-0.27), versus $-0.34 a year earlier. Full-year consensus is $-1.14, growing to $-1.04 the year after.
REVENUE · NEXT QUARTER
$22.7M
Range $22.4M – $22.8M · 5 analysts · +5% YoY
Revenue is expected to reach $22.7M (range $22.4M – $22.8M), +5.4% year-over-year. Full-year consensus is $90.8M, rising to $98.1M next year.
Top analysts covering Pulmonx Corp
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on LUNG.
#1
Jason Bednar
Piper Sandler · Rank #303
Hold
$2.50+104.1% to target
Overall win rate
33%
+ Follow
#2
Frank Takkinen
Lake Street · Rank #327
Buy
$4.00+226.5% to target
Overall win rate
26%
+ Follow
#3
Jason Kolbert
D. Boral Capital · Rank #346
Buy
$14.00+1042.9% to target
Overall win rate
22%
+ Follow
#4
LB
Larry Biegelsen
Wells Fargo
Hold
$3.00+144.9% to target
Coverage
—
+ Follow
#5
Joanne Wuensch
Citigroup
Hold
$4.15+238.8% to target
Coverage
—
+ Follow
LUNG stock forecast FAQ
What is LUNG's average 12-month price target?+
The 6 analysts with a live target average $5.58 for Pulmonx Corp over the next 12 months, ranging from a $14.00 high to a $2.50 low.
Is LUNG stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 6 analyst ratings, 4 are Buy or Strong Buy, 2 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for LUNG?+
The Street-high target is $14.00 (D. Boral Capital), and the Street-low is $2.50 (Piper Sandler). The average of all 6 active targets is $5.58.
How many Wall Street analysts cover LUNG?+
6 analysts have an active rating on Pulmonx Corp, and 6 firms carry a live 12-month price target.
Who is the most accurate analyst covering LUNG?+
Among analysts who currently cover LUNG, Jason Bednar of Piper Sandler has the strongest overall Quantellect track record (Rank #303). Their current call is Hold with a $2.50 target.
What is Pulmonx Corp's projected EPS for next quarter?+
The consensus estimate is $-0.29 per share (range $-0.30 – $-0.27) across 5 analysts. Full-year EPS is projected at $-1.14, rising to $-1.04 the following year.
How much revenue is Pulmonx Corp expected to report next quarter?+
Consensus revenue is $22.7M (range $22.4M – $22.8M). Full-year revenue is projected at $90.8M, growing to $98.1M next year.
Have analysts been upgrading or downgrading LUNG lately?+
As of Jul, 3 of 4 firms rate LUNG a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their LUNG calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
